Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion
February 14th, 2025
Interbody fusion of the lumbar spine can be achieved surgically using different techniques. Minimally invasive techniques, including lateral interbody fusion, have been developed within recent decades to reduce rates of complications and allow for quicker patient recovery. We provide insight into stand-alone lateral trans-psoas interbody fusion, highlighting potential complications and pitfalls.
Extreme lateral and direct lateral lumbar interbody fusion may be a viable treatment option for degenerative lumbar disease if non-surgical treatment fails. It shows notable benefits such as minimal blood loss, preservation of posterior structures, ability to perform an extensive discectomy, and placement of large intervertebral cages. Potential disadvantages include damage to nerves, vessels, or injuries to abdominals organs.
After completing the preoperative imaging, including CT or MRI scans and X-ray images to assess for instability, confirm the surgical level with fluoroscopy images. Use skin markers to visualize the disc space. Make a three to five centimeter long skin incision over the disc space in a single-level surgery.
Open the fascia and use clamps to bluntly split this three layers of the oblique muscles until you reach the retroperitoneal space. Identify the psoas and split it in a longitudinal direction. Look out for any changes in somatosensory evoked potentials, motor evoked potentials, and spontaneous electromyography during approach and when dissecting psoas using a handheld EMG probe.
After fluoroscopically confirming the correct level, place a self-retaining retractor system. Here, use a scalpel to perform an annulotomy and resect all discal material using a rongeur. Carefully remove any remaining disc material and cartilage from both endplates using Cobb or curettes.
Use different trial components to restore normal disc height and to relieve any pressure on nerve roots. Use fluoroscopy in both AP and lateral views to confirm correct trial position. After identifying the correct size, the final cage is implanted under fluoroscopic guidance.
Check for hemostasis and remove retractors carefully. The wound is closed in a multi-layered fashion. In a recent study, we investigated the complication rates following a standalone lateral interbody fusion.
We retrospectively investigated 158 patients who received an LF between 2016 and 2020 with a mean followup of 14 months. The primary pathologies was stenosis due to adult deformity and isolated stenosis. The average blood loss was 121 milliliters.
Most patients received a single-level fusion in both study cohorts. However, in the trans-psoas group, one patient received a three-level fusion. Overall, we observed a complication rate of 19.6%The most prevalent complication observed was a temporary weakness of the hip flexor on the same side as the surgical procedure.
The weakness, however, was complete resolved in all patients by the final clinical follow-up. A single patient endured permanent nerve damage to the femoral nerve. Wound complications were found in 1.3%and symptomatic pseudarthoris in 2.1%during follow up.
A recurrent stenosis was the imminent reason for revision at 4.1%after a mean of 239 days. In addition to our analysis, Walker et al showed in their systematic review that most common complications were transient sensory symptoms at 21.7%A transient hip flexor motor weakness was found at 19.7%Persistent neurological symptoms were found in 2.8%of all cases, whereas wound infection was reported in 3.1%Many studies have shown that a standalone lateral interbody fusion is a relatively safe procedure for treatment of certain types of generative lumbar spine disease, foraminal stenosis, and some adult deformities. Utilizing neuromonitoring offers a reduced muscle disruption and potentially a faster recovery.
However, the procedure is recommended to be performed by a skilled surgical team well-versed in neuromonitoring and lateral access to spine surgery techniques.
View the full transcript and gain access to thousands of scientific videos
Overview
This article discusses the surgical techniques for interbody fusion of the lumbar spine, focusing on minimally invasive approaches like lateral interbody fusion. It highlights the benefits and potential complications associated with these techniques.
Key Study Components
Area of Science
- Neurosurgery
- Orthopedics
- Minimally Invasive Surgery
Background
- Interbody fusion is a common surgical procedure for lumbar spine issues.
- Minimally invasive techniques aim to reduce complications and recovery time.
- Understanding the risks and benefits is crucial for surgical success.
- Recent advancements have improved surgical outcomes.
Purpose of Study
- To evaluate the effectiveness of lateral interbody fusion techniques.
- To identify potential complications and pitfalls in the procedure.
- To provide insights into preoperative planning and execution.
Methods Used
- Preoperative imaging including CT, MRI, and X-ray scans.
- Fluoroscopy for confirming surgical levels.
- Skin markers for visualizing the disc space.
- Minimally invasive surgical techniques for interbody fusion.
Main Results
- Minimally invasive techniques result in less blood loss.
- Preservation of posterior structures is achieved.
- Ability to perform extensive discectomy and place large intervertebral cages.
- Potential risks include nerve and vessel damage.
Conclusions
- Lateral interbody fusion is a viable option for degenerative lumbar disease.
- Careful preoperative planning can mitigate risks.
- Further research is needed to optimize surgical techniques.
Frequently Asked Questions
Executive Industry Relevance
Minimally invasive lateral trans-psoas interbody fusion addresses the challenge of reducing surgical morbidity in degenerative lumbar spine disease, supporting faster recovery and lower complication rates. For biopharma R&D, such procedures provide a controlled platform for evaluating perioperative interventions, device-tissue compatibility, and neuromonitoring strategies. The method's reproducibility and quantifiable complication rates enable robust translational research and device validation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables systematic evaluation of device-tissue interactions in a defined surgical context.
- Supports mechanistic de-risking for perioperative pharmacological interventions.
- Facilitates quantification of neuromuscular and vascular complication profiles.
Screening & Assay Development
- Provides a standardized surgical model for assessing biomaterial or device performance.
- Enables reproducible measurement of intraoperative neuromonitoring outputs.
- Supports development of quantitative endpoints for post-surgical recovery and complication rates.
Translational & Preclinical Research
- Aligns with disease-relevant models for evaluating interventions in spinal degeneration and repair.
- Enables continuity from device or drug discovery through preclinical validation in a clinically relevant setting.
- Supports risk-adjusted advancement of perioperative therapeutics and neuromonitoring technologies.
Pipeline & Workflow Integration
This surgical model fits within the translational continuum from device or therapeutic discovery to preclinical validation and clinical feasibility studies.
- Discovery Biology: Supports hypothesis testing for device safety and perioperative intervention efficacy.
- Screening: Enables reproducible assessment of neuromonitoring and complication endpoints.
- Analytics: Provides quantitative complication rates and recovery metrics for comparative analysis.
- Translational Research: Bridges discovery and preclinical validation in a disease-relevant surgical context.
- Enterprise Reuse: Establishes a reusable platform for iterative device, biomaterial, or pharmacological evaluation.
Operational & Enterprise Impact
- Scientific Value: Enhances predictive confidence in device and intervention safety profiles.
- Operational Value: Standardizes complication tracking and neuromonitoring outputs for cross-study comparison.
- Strategic Value: Informs go/no-go decisions for perioperative and device-related R&D investments.
- Portfolio Impact: Supports risk-adjusted prioritization of surgical and perioperative innovation programs.
Implementation Considerations
- Requires surgical expertise in lateral access and neuromonitoring techniques.
- Demands access to advanced imaging and intraoperative monitoring infrastructure.
- Necessitates standardized complication and outcome tracking across studies.
- May require adaptation for different spinal levels or patient populations.
- Complication rates and recovery endpoints must be rigorously quantified for translational relevance.
